Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies.
Malard F, Gaugler B, Gozlan J, Bouquet L, Fofana D, Siblany L, Eshagh D, Adotevi O, Laheurte C, Ricard L, Dulery R, Stocker N, van de Wyngaert Z, Genthon A, Banet A, Memoli M, Ikhlef S, Sestilli S, Vekhof A, Brissot E, Marjanovic Z, Chantran Y, Cuervo N, Ballot E, Morand-Joubert L, Mohty M.
Malard F, et al. Among authors: van de wyngaert z.
Blood Cancer J. 2021 Aug 10;11(8):142. doi: 10.1038/s41408-021-00534-z.
Blood Cancer J. 2021.
PMID: 34376633
Free PMC article.